RTA Laboratuvarlari Biyolojik (RTALB) — Cash Flow Quality Index
RTA Laboratuvarlari Biyolojik (RTALB) has a Cash Flow Quality Index of 0.23x as of June 2025. Operating cash flow of TL20.98 Million is below net income of TL91.75 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore RTALB strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
RTA Laboratuvarlari Biyolojik Cash Flow Quality Index (2014–2024)
Historical Cash Flow Quality Index for RTA Laboratuvarlari Biyolojik across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check RTA Laboratuvarlari Biyolojik tangible book value ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for RTA Laboratuvarlari Biyolojik (2014–2024)
Year-by-year earnings quality comparison for RTA Laboratuvarlari Biyolojik. For live market cap and the full company financial profile, see RTALB market cap overview.
| Year | Quality Index | Operating CF (TRY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -1.62x | TL-84.45 Million | TL52.23 Million | ▼ -222.7% |
| 2022 | -0.50x | TL-140.82 Million | TL281.12 Million | ▼ -183.4% |
| 2021 | 0.60x | TL68.78 Million | TL114.47 Million | ▲ +290.7% |
| 2020 | 0.15x | TL9.37 Million | TL60.93 Million | ▼ -81.0% |
| 2019 | 0.81x | TL3.58 Million | TL4.42 Million | ▲ +130.6% |
| 2018 | -2.64x | TL-5.81 Million | TL2.20 Million | ▼ -881.0% |
| 2017 | 0.34x | TL1.41 Million | TL4.16 Million | ▼ -51.7% |
| 2016 | 0.70x | TL2.86 Million | TL4.09 Million | ▼ -15.4% |
| 2015 | 0.83x | TL6.18 Million | TL7.48 Million | ▲ +45.3% |
| 2014 | 0.57x | TL2.58 Million | TL4.54 Million | — |